Keratinocyte Transplantation—New Option for Skin Coverage After Burns?
Emerging Technique May Overcome Disadvantages of Other Skin Graft Alternatives, Suggests Review in PRS GO
A transplantation technique using the patient's own skin cells—without the need for prolonged culture—may provide a new alternative for skin coverage in burn patients, suggests a report in Plastic and Reconstructive Surgery—Global Open®, the official open-access medical journal of the American Society of Plastic Surgeons (ASPS).
The technique, called autologous keratinocyte transplantation, may help to overcome the drawbacks of existing options for skin coverage of large burns, according to the article by Dr Jiad Noel Mcheik of CHU de Poitiers, France, and colleagues.
Alternatives for Skin Coverage of Large Burn Wounds
Providing skin coverage for large burn wounds is a "tricky clinical problem" in plastic and reconstructive surgery, the authors write. In addition to physiologic abnormalities caused by major burns, there is often simply not enough normal skin available for grafting.
Split-thickness skin grafting remains the standard technique, with a success rate of nearly 95 percent. There is also a high rate of complications at the skin graft donor site, including pain and scarring.
For patients with large burns who don't have adequate tissue for skin grafting, alternative techniques are available. These include a "mesh" technique to extend the size of the available graft and microskin grafting using tiny "diced" pieces of skin graft can be used for patients with major burns.
Another option is the use of cultured epithelial autograft (CEA)—sheets of the patient's own epithelial cells, grown in the laboratory. But while CEA is potentially lifesaving in severely burned patients, it has important limitations—including long culture time and the need for special laboratory techniques.
Keratinocyte Grafting—A New Alternative?
Against this backdrop, Dr Mcheik and colleagues believe that transplantation of keratinocytes—the most common type of cell in the outermost skin layer—is a "turning point in skin grafting." In this technique, keratinocytes are isolated then transplanted in a "pre-confluent" state—before they form a sheet of skin, as in CEA.
By avoiding the need for skin cell culture, this technique allows the burned area to be covered within a few days, compared to the several weeks required for CEA. Keratinocyte transplantation also has other advantages related to the fact that the transplanted cells proliferate and develop in the wound site. Dr Mcheik and coauthors note recent experiments showing encouraging results with keratinocyte transplantation using both allografts (donated cells) and autografts (patient's own cells). In a preliminary study of boys with burn injuries, they achieved excellent results using keratinocytes isolated from the boys' own foreskins. That study highlights the importance of "choosing an optimal donor site containing cells with high proliferative capacity," according to the authors.
Dr Mcheik and colleagues note that some important questions remain to be answered about autologous transplantation—including the optimal source, cell type, and transplantation technique; and the final outcomes, including new skin generation and scarring. They conclude: "Successful clinical results and the easy management of the keratinocyte isolation procedure in the operating room allowed us to design the non-cultured autologous keratinocyte transplantation as a standard procedure, which can be added to the arsenal of therapies for burned patients in surgical units everywhere."
Plastic and Reconstructive Surgery—Global Open® is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health.
About PRS Global Open
Plastic and Reconstructive Surgery—Global Open (PRS Global Open) is an open access, rigorously peer-reviewed, international journal focusing on global plastic and reconstructive surgery. PRS Global Open educates and supports plastic surgeons globally to provide the highest quality patient care and maintain professional and ethical standards through education, research, and advocacy.
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.